These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36134203)

  • 41. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): part I. Albumin-bound betulinic acid nanoparticles (ABBns).
    Srivari Y; Chatterjee P
    J Microencapsul; 2016 Dec; 33(8):689-701. PubMed ID: 27707051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo.
    Cheng M; Li Q; Wan T; Hong X; Chen H; He B; Cheng Z; Xu H; Ye T; Zha B; Wu J; Zhou R
    J Biomed Mater Res B Appl Biomater; 2011 Oct; 99(1):70-80. PubMed ID: 21656667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination therapy with doxorubicin-loaded galactosylated poly(ethyleneglycol)-lithocholic acid to suppress the tumor growth in an orthotopic mouse model of liver cancer.
    Singh B; Jang Y; Maharjan S; Kim HJ; Lee AY; Kim S; Gankhuyag N; Yang MS; Choi YJ; Cho MH; Cho CS
    Biomaterials; 2017 Feb; 116():130-144. PubMed ID: 27914985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Green Tea Extract Encapsulated Into Chitosan Nanoparticles on Hepatic Fibrosis Collagen Fibers Assessed by Atomic Force Microscopy in Rat Hepatic Fibrosis Model.
    Safer AM; Hanafy NA; Bharali DJ; Cui H; Mousa SA
    J Nanosci Nanotechnol; 2015 Sep; 15(9):6452-9. PubMed ID: 26716199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved oral delivery of insulin by PLGA nanoparticles coated with 5
    Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L
    Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
    Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
    J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poly(lactic-
    Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
    Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
    Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
    Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel nanoparticles based on chitosan-dicarboxylate conjugates via tandem ionotropic/covalent crosslinking with tripolyphosphate and subsequent evaluation as drug delivery vehicles.
    Dmour I; Taha MO
    Int J Pharm; 2017 Aug; 529(1-2):15-31. PubMed ID: 28634140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Betulinic acid attenuates liver fibrosis by inducing autophagy via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway.
    Liu Y; Bi Y; Mo C; Zeng T; Huang S; Gao L; Sun X; Lv Z
    J Nat Med; 2019 Jan; 73(1):179-189. PubMed ID: 30377904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells.
    Mi FL; Wu YY; Chiu YL; Chen MC; Sung HW; Yu SH; Shyu SS; Huang MF
    Biomacromolecules; 2007 Mar; 8(3):892-8. PubMed ID: 17316043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Betulinic acid and betulin ameliorate acute ethanol-induced fatty liver via TLR4 and STAT3 in vivo and in vitro.
    Wan Y; Jiang S; Lian LH; Bai T; Cui PH; Sun XT; Jin XJ; Wu YL; Nan JX
    Int Immunopharmacol; 2013 Oct; 17(2):184-90. PubMed ID: 23816536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
    Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.
    Wang R; Yang M; Li G; Wang X; Zhang Z; Qiao H; Chen J; Chen Z; Cui X; Li J
    Colloids Surf B Biointerfaces; 2019 Feb; 174():270-279. PubMed ID: 30469048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.
    Wei B; He L; Wang X; Yan GQ; Wang J; Tang R
    J Biomater Appl; 2017 Aug; 32(2):206-218. PubMed ID: 28618976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoic acid-conjugated chitosan/manganese porphyrin ionic-complex nanoparticles for improved T
    Tran HP; Jiang Y; Nguyen PH; Kim JJ; Yang SG
    J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):382-391. PubMed ID: 34309195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
    Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
    J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors.
    Kong F; Tang C; Yin C
    Bioconjug Chem; 2020 Oct; 31(10):2446-2455. PubMed ID: 32991164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.